Citadel Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.77M Sell
33,100
-8,600
-21% -$505K ﹤0.01% 6342
2025
Q4
$2.59M Sell
41,700
-5,300
-11% -$327K ﹤0.01% 5443
2025
Q3
$2.82M Sell
47,000
-23,700
-34% -$1.45M ﹤0.01% 5411
2025
Q2
$4.43M Sell
70,700
-4,300
-6% -$258K ﹤0.01% 4334
2025
Q1
$4.51M Sell
75,000
-70,300
-48% -$4.37M ﹤0.01% 4044
2024
Q4
$8.48M Buy
145,300
+77,300
+114% +$4.59M ﹤0.01% 3197
2024
Q3
$4.03M Sell
68,000
-2,600
-4% -$148K ﹤0.01% 4302
2024
Q2
$3.96M Sell
70,600
-51,100
-42% -$2.86M ﹤0.01% 4118
2024
Q1
$7.13M Buy
121,700
+14,900
+14% +$842K ﹤0.01% 3412
2023
Q4
$5.76M Buy
106,800
+27,900
+35% +$1.36M ﹤0.01% 3585
2023
Q3
$3.83M Buy
78,900
+42,500
+117% +$2.26M ﹤0.01% 4082
2023
Q2
$2.06M Buy
36,400
+18,800
+107% +$1.04M ﹤0.01% 5104
2023
Q1
$950K Sell
17,600
-32,900
-65% -$1.75M ﹤0.01% 6883
2022
Q4
$2.65M Buy
50,500
+31,500
+166% +$1.6M ﹤0.01% 4959
2022
Q3
$896K Sell
19,000
-40,700
-68% -$2.11M ﹤0.01% 7228
2022
Q2
$3.01M Buy
59,700
+36,900
+162% +$2.01M ﹤0.01% 4749
2022
Q1
$1.39M Sell
22,800
-30,800
-57% -$1.84M ﹤0.01% 6909
2021
Q4
$3.53M Buy
53,600
+4,600
+9% +$294K ﹤0.01% 5012
2021
Q3
$3.08M Buy
49,000
+14,800
+43% +$944K ﹤0.01% 5298
2021
Q2
$2.06M Buy
34,200
+8,400
+33% +$486K ﹤0.01% 6553
2021
Q1
$1.42M Buy
+25,800
New +$1.43M ﹤0.01% 7234

Other funds holding IHI

Citadel Advisors's IHI Position: Q1 2026 in Review

Citadel Advisors sold out of iShares US Medical Devices ETF (IHI) in Q1 2026, closing a stake of 49,552 shares — an estimated $2.91M sold.

Citadel Advisors first reported a position in IHI in Q4 2014 and held it in 31 quarters. The position peaked at $12.1M in Q1 2024. 503 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Citadel Advisors reported no remaining iShares US Medical Devices ETF position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 49,552 iShares US Medical Devices ETF shares in Q1 2026, an estimated $2.91M.
  • Citadel Advisors first reported a position in iShares US Medical Devices ETF in Q4 2014 and held it in 31 quarters.
  • Citadel Advisors's iShares US Medical Devices ETF position peaked at $12.1M in Q1 2024.
  • 503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.